Cantel Medical Corp. operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cantel Medical Corp. with three other
companies in this sector in the United States:
sales of $418.79 million
of which 53%
of which 96%
was Impella product revenue), and
of which 41%
was North America Plasma).
During the year ended July of 2019, sales at
Cantel Medical Corp. were $918.16 million.
increase of 5.3%
versus 2018, when the company's sales were $871.92 million.
This was the fifth consecutive year of sales increases at Cantel Medical Corp.
(and since 2014, sales have increased a total of 88%).